ARTICLE
|
doi:10.20944/preprints202401.0336.v1
Subject:
Medicine And Pharmacology,
Urology And Nephrology
Keywords:
circulating tumor cells (CTCs); enzalutamide; bone metastases; castration-resistant prostate cancer; androgen receptor signaling inhibitor
Online: 4 January 2024 (11:29:18 CET)